Every year, more than 30,000 Europeans die as a result of antibiotic-resistant superbugs, bacteria that are evolving so rapidly that existing treatment options cannot eradicate them.
But the problem is not just a deadly drug resistance to bacterial spread. We must also worry drug-resistant fungal infections. Indeed, called a deadly and resistant fungus Candida auris, is spreading worldwide and causing some Centers for Disease Control and Prevention (CDC) urgent threats ".
It was in 2009 that doctors discovered C. Auris for the very first time, in the auricular discharge of a patient in Japan. Since then, the fungus has spread to the United States and other countries, including Colombia, India and South Korea.
The CDC reported the first seven cases of C. Auris in the United States in August 2016. In May 2017, a total of 77 cases were reported in New York, New Jersey, Illinois, Indiana, Maryland, Massachusetts, and Oklahoma. . By analyzing the people who came in contact with the first 77 cases, the CDC found that the fast-growing fungus had infected an additional 45 people. In February 2019, there were 587 confirmed cases C. Auris only in the United States.
Still according to the CDC, C. Auris usually affects people who have weakened the immune system, are hospitalized or have serious illnesses. In fact infections C. Auris have been reported in hospitals and health centers around the world.
An intensive care unit was closed in the United Kingdom after it was discovered that 72 people were infected. In Spain, a hospital discovered that many patients were carriers of the fungus: 41% of patients with the fungus died within 30 days of diagnosis.
C. Auris is particularly concerned about health experts because it cannot be eradicated by the usual medical treatments. Moreover, according to the CDC, this mushroom even has the ability to survive for weeks on surfaces such as walls and furniture. Indeed, some infections C. Auris have resisted the three main classes of antifungal agents. In such situations, different classes of high-dose antifungal agents should be used to treat the infection, but this is a less controlled type of treatment and less likely to succeed.
People who contract these drug-resistant diseases usually die shortly after diagnosis due to the difficult-to-treat nature of the disease. Namely that the majority of fungal and bacterial infections can be stopped with medication. However, the genes for fungi and resistant bacteria are evolving so quickly that treatments are simply ineffective, causing the disease to spread.
To make matters worse, many people have no symptoms and so the diseases spread unknowingly. According to the CDC, 1 in 10 people diagnosed with super bacteria is not aware of a resistant disease.
Moreover " a person may not be infected with C. Auria if they already have another disease "Explain the CDC on their website. For example, fever and chills that have difficulty stopping due to taking medication are classic symptoms C. Auris, but the only way to detect if it is the fungus is to perform laboratory tests.
You may also want: A study has explained how a pathogenic fungus can weaken the immune system
Currently, doctors and researchers still don't know exactly what causes these drug-resistant diseases, but they know there are different strains C. Auris, in different parts of the world. Some experts believe that the intensive use of pesticides and other antifungal treatments has led to this C. Auris in different places in the worldin about the same time. In 2013, researchers discovered another resistant fungus, called Aspergillus and noted that it existed in areas where it was the target of a pesticide.
Because pesticides, antifungal agents and antibiotics are still used on crops and livestock, it is possible that the fungi and bacteria they target may learn to evolve to stay alive.
Until researchers are able to determine the exact cause (s) of these resistant diseases, the CDC tells all medical staff to use soap and hand sanitizer before and after touching patients. The CDC strongly encourages that all cases be reported to the public health services without delay.